News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Shetzline Michael
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/24/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 10,324 shares
@ $10.12, valued at
$104.5k
|
|
05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/10/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 69,869 shares
@ $0 Granted 34,935 options to buy
@ $0 |
|
03/01/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 7,146 shares
@ $11.41, valued at
$81.5k
Sold 2,322 shares
@ $11.41, valued at
$26.5k
Sold 7,438 shares
@ $11.31, valued at
$84.1k
Sold 2,416 shares
@ $11.31, valued at
$27.3k
|
|
01/19/2023 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 14,663 shares
@ $0 |
|
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2022 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 29,326 shares
@ $0 |
|
11/24/2021 |
4
| Shetzline Michael (CMO,SVP,Head-Res&Drug) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 13,776 shares
@ $11.58, valued at
$159.5k
|
|
05/26/2021 |
4
| Shetzline Michael (CMO, SVP & Head of Drug Devt.) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Sold 2,077 shares
@ $12.25, valued at
$25.4k
|
|
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/28/2020 |
4
| Shetzline Michael (CMO, SVP & Head of Drug Devt.) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns:
| Granted 20,740 shares
@ $0 |
|
04/21/2020 |
3
| Shetzline Michael (CMO, SVP & Head of Drug Devt.) has filed a Form 3 on IRONWOOD PHARMACEUTICALS INC |
|
|